Year |
Citation |
Score |
2023 |
Zhang X, Wang Y, Supekar S, Cao X, Zhou J, Dang J, Chen S, Jenkins L, Marsango S, Li X, Liu G, Milligan G, Feng M, Fan H, Gong W, et al. Pro-phagocytic function and structural basis of GPR84 signaling. Nature Communications. 14: 5706. PMID 37709767 DOI: 10.1038/s41467-023-41201-0 |
0.311 |
|
2023 |
Zhang X, Weiß T, Cheng MH, Chen S, Ambrosius CK, Czerniak AS, Li K, Feng M, Bahar I, Beck-Sickinger AG, Zhang C. Structural basis of CMKLR1 signaling induced by chemerin9. Biorxiv : the Preprint Server For Biology. PMID 37333145 DOI: 10.1101/2023.06.09.544295 |
0.461 |
|
2023 |
Zhang X, Wang Y, Supekar S, Cao X, Zhou J, Dang J, Chen S, Jenkins L, Marsango S, Li X, Liu G, Milligan G, Feng M, Fan H, Gong W, et al. Pro-phagocytic function and structural basis of GPR84 signaling. Research Square. PMID 36824923 DOI: 10.21203/rs.3.rs-2535247/v1 |
0.548 |
|
2022 |
Cao X, Lai SWT, Chen S, Wang S, Feng M. Targeting tumor-associated macrophages for cancer immunotherapy. International Review of Cell and Molecular Biology. 368: 61-108. PMID 35636930 DOI: 10.1016/bs.ircmb.2022.02.002 |
0.592 |
|
2021 |
Chen S, Lai SWT, Brown CE, Feng M. Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy. Frontiers in Immunology. 12: 635173. PMID 33790906 DOI: 10.3389/fimmu.2021.635173 |
0.555 |
|
2021 |
Cao X, Li B, Chen J, Dang J, Chen S, Gunes EG, Xu B, Tian L, Muend S, Raoof M, Querfeld C, Yu J, Rosen ST, Wang Y, Feng M. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer. Journal For Immunotherapy of Cancer. 9. PMID 33753567 DOI: 10.1136/jitc-2020-002022 |
0.568 |
|
2021 |
Chen S, Lai SWT, Brown CE, Feng M. Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy Frontiers in Immunology. 12. DOI: 10.3389/fimmu.2021.635173 |
0.398 |
|
2020 |
Chen J, Cao X, Li B, Zhao Z, Chen S, Lai SWT, Muend SA, Nossa GK, Wang L, Guo W, Ye J, Lee PP, Feng M. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance. Frontiers in Immunology. 11: 621757. PMID 33603751 DOI: 10.3389/fimmu.2020.621757 |
0.604 |
|
2020 |
Chen RH, Xiao ZW, Yan XQ, Han P, Liang FY, Wang JY, Yu ST, Zhang TZ, Chen SQ, Zhong Q, Huang XM. Tumor Cell-Secreted ISG15 Promotes Tumor Cell Migration and Immune Suppression by Inducing the Macrophage M2-Like Phenotype. Frontiers in Immunology. 11: 594775. PMID 33424843 DOI: 10.3389/fimmu.2020.594775 |
0.329 |
|
2019 |
Chen S, Wainwright DA, Wu JD, Wan Y, Matei DE, Zhang Y, Zhang B. CD73: an emerging checkpoint for cancer immunotherapy. Immunotherapy. PMID 31223045 DOI: 10.2217/Imt-2018-0200 |
0.313 |
|
2018 |
Wu X, Chen S, Lin L, Liu J, Wang Y, Li Y, Li Q, Wang Z. A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor Activities. Translational Oncology. 11: 366-373. PMID 29455083 DOI: 10.1016/J.Tranon.2018.01.024 |
0.42 |
|
2017 |
Zhang M, Dominguez D, Chen S, Fan J, Qin L, Long A, Li X, Zhang Y, Shi H, Zhang B. WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability. Oncology Letters. 14: 3580-3586. PMID 28927115 DOI: 10.3892/Ol.2017.6584 |
0.313 |
|
2017 |
Zhao Q, Liu T, Hong B, Wang F, Zhou C, Du X, Chen S, Deng X, Duoerkun S, Li Q, Yang Y, Gong K, Zhang N. Vascular Endothelial Growth Inhibitor, a Cytokine of the Tumor Necrosis Factor Family, is Associated With Epithelial-Mesenchymal Transition in Renal Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 28362712 DOI: 10.1097/Pai.0000000000000517 |
0.304 |
|
2016 |
Li J, Zhou C, Dong B, Zhong H, Chen S, Li Q, Wang Z. Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity. Cancer Biology & Therapy. 0. PMID 27645568 DOI: 10.1080/15384047.2016.1235659 |
0.353 |
|
2016 |
Chen S, Li J, Li Q, Wang Z. Bispecific Antibodies in Cancer Immunotherapy. Human Vaccines & Immunotherapeutics. 0. PMID 27249163 DOI: 10.1080/21645515.2016.1187802 |
0.384 |
|
2016 |
Dong B, Zhou C, He P, Li J, Chen S, Miao J, Li Q, Wang Z. A novel bispecific antibody, BiSS, with potent anti-cancer activities. Cancer Biology & Therapy. 0. PMID 26828900 DOI: 10.1080/15384047.2016.1139266 |
0.387 |
|
2015 |
Huang Q, Zhou C, Chen X, Dong B, Chen S, Zhang N, Liu Y, Li A, Yao M, Miao J, Li Q, Wang Z. Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib. Plos One. 10: e0141395. PMID 26513662 DOI: 10.1371/Journal.Pone.0141395 |
0.321 |
|
2015 |
Li L, He P, Zhou C, Jing L, Dong B, Chen S, Zhang N, Liu Y, Miao J, Wang Z, Li Q. A Novel Bispecific Antibody, S-Fab, Induces Potent Cancer Cell Killing. Journal of Immunotherapy (Hagerstown, Md. : 1997). 38: 350-6. PMID 26448579 DOI: 10.1097/Cji.0000000000000099 |
0.412 |
|
2015 |
Chen S, Liu J, Huang Q, Xing J, Zhang N, Liu Y, Wang Z, Li Q. A targeted IL-15 fusion protein with potent anti-tumor activity. Cancer Biology & Therapy. 0. PMID 26176990 DOI: 10.1080/15384047.2015.1071739 |
0.303 |
|
Show low-probability matches. |